“…This alternating microcurrent stimulation is suggested to act via several mechanisms: neurotrophic, anti-apoptotic, anti-glutammatic, and anti-inflammatory (Sehic et al, 2016). For this reason, tcES is used to treat nonarteritic ischemic optic neuropathy (NAION) (Fujikado et al, 2006), retinal artery occlusion (RAO) (Inomata et al, 2007;Oono et al, 2011;Naycheva et al, 2013), traumatic optic neuropathy (TON) (Fujikado et al, 2006), retinitis pigmentosa (Schatz et al, 2011(Schatz et al, , 2017Robles-Camarillo et al, 2013;Bittner et al, 2018aBittner et al, , 2018b, and macular dystrophy (Ozeki et al, 2013). We examined 11 papers on tcES.…”